Skip to Content

Margaret L. Kripke Legend Award

For Promotion of Women in Cancer Medicine and Cancer Science

2014 Recipient of the Margaret L. Kripke Legend Award
Laurie Glimcher, M.D.
Dean, Weill Cornell Medical College
Provost, Medical Affairs of Cornell University  

Dr. Laurie Glimcher

Weill Cornell is led by Laurie H. Glimcher, MD, the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College. Dr. Glimcher also serves as Provost for Medical Affairs of Cornell University. She holds a Professor of Medicine appointment at the Medical College. Dr. Glimcher was recruited to Weill Cornell in 2012 from Harvard, where she was the Irene Heinz Given Professor of Immunology and Director of the Division of Biological Sciences at the Harvard School of Public Health, and Professor of Medicine at Harvard Medical School, where she headed one of the top immunology programs in the world. She also served as Senior Physician and Rheumatologist at the Brigham and Women’s Hospital.

Dr. Glimcher received her postdoctoral training at Harvard and in the Laboratory of Immunology at the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, and is board certified in Internal Medicine and Rheumatology. She received her BA degree from Radcliffe College and her MD from Harvard Medical School. As an immunologist, her primary research interests are the biochemical and genetic approaches that elucidate the molecular pathways that regulate CD4 T helper cell development and activation. The complex regulatory pathways governing T helper cell responses are critical for both the development of protective immunity and for the pathophysiologic immune responses underlying autoimmune, infectious and malignant diseases. Dr. Glimcher’s research laboratory has studied the transcriptional pathways that control this important immune checkpoint, leading to many discoveries, including the T-bet and XBP-1 transcription factors, which regulate a variety of immune functions. Most recently, her laboratory has identified new proteins that control osteoblast and osteoclast commitment and activation in skeletal biology with significant implications for diseases of bone, including osteoporosis, osteoarthritis and cancer metastasis to bone.

Dr. Glimcher is the recipient of numerous awards and honors, including the Soma Weiss Award for Undergraduate Research, the Distinguished Young Investigator Award from the American College of Rheumatology, the Leukemia Society’s Stohlman Memorial Scholar Award, the Arthritis Foundation’s Lee S. Howley Award, the FASEB Excellence in Science Award, the American Society of Clinical Investigation Investigator Award, the Klemperer Award, the AAUW Senior Scholar Award, the Huang Meritorious Career Award, the AAI Excellence in Mentoring Award, the Dean’s Award for Leadership in the Advancement of Women Faculty, the American College of Rheumatology Distinguished Investigator Award, In 2012 she received the Ernst W. Bertner Memorial Award, MD Anderson Cancer Center, the William B. Coley Award, Cancer Research Institute, and the Luis Federico Leloir Prize to International Cooperation in Science, Technology and Innovation, Ministry of Health, Argentina.

She is a Fellow of the American Academy of Arts and Sciences, a Member of the Institute of Medicine of the National Academy of Sciences and a Member of the National Academy of Sciences. She is the former President of the American Association of Immunologists. She is a member of the American Asthma Foundation, , Health Care Ventures, and the Cancer Research Institute Scientific Advisory Boards. She is on the Board of Trustees of the Memorial Sloan Kettering Cancer Center and the New York Blood Foundation. She is on the Corporate Board of Directors of the Bristol-Myers Squibb Pharmaceutical Corporation and the Waters Corporation.

Dr. Glimcher speaks nationally and internationally on rheumatology, immunology, skeletal biology and translational medicine and has contributed more than 350 scholarly articles and papers to the medical literature.

Laurie Glimcher received her award on Thursday, March 13, 2014.


Prior Award Recipients

2013 Recipient:
Karen Antman, M.D.
Provost, Boston University Medical Campus
Dean, Boston University School of Medicine

2012 Recipient:
Nancy Hopkins, Ph.D.
Amgen, Inc. Professor of Biology
Massachusetts Institute of Technology

2011 Recipient:
Edward J. Benz, Jr., M.D. (pdf)
President, Dana-Farber Cancer Institute
Director, Dana-Farber/Harvard Cancer Center
Richard and Susan Smith Professor of Medicine, Harvard Medical School
Professor of Pediatrics, Harvard Medical School
Professor of Pathology, Harvard Medical School

2010 Recipient:
Janet Rowley, M.D. (pdf)
Blum-Riese Distinguished Service Professor of Medicine, of Molecular Genetics and Cell Biology,
and of Human Genetics, Section of Hematology/Oncology
University of Chicago Medical Center

2009 Recipient:
Margaret Foti, Ph.D., M.D. (h.c.) (pdf)
CEO, American Association for Cancer Research

About Margaret L. Kripke

Margaret L. Kripke, Ph.D., is widely regarded as a trailblazer and role model for women in medical science, academia and executive leadership. She has supported and mentored countless colleagues, employees and trainees throughout her distinguished career. Dr. Kripke continues to serve on the MD Anderson Cancer Center faculty in a reduced-time capacity as special advisor to the provost.   More (pdf)

About the Margaret L. Kripke Legend Award

Women Faculty Programs at MD Anderson Cancer Center established this award in 2008 in honor of Margaret L. Kripke, Ph.D., for her unwavering advocacy for and promotion of women in academic medicine and science.

This national award will be given each year to an individual, male or female, for their ongoing sustained support and extraordinary dedication to enhancing the careers of women in cancer medicine and cancer science.

Candidates for the award will be considered by a committee of internal faculty and external members of the scientific community.

For questions, please contact:
Abby Mitchell, MBA
Project Director
P: 713.792.6142

© 2014 The University of Texas MD Anderson Cancer Center